Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.80725775 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 4.76546735 |
3 | Golgi transport vesicle coating (GO:0048200) | 4.76546735 |
4 | negative T cell selection (GO:0043383) | 4.75499760 |
5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.74040354 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.74040354 |
7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.73791196 |
8 | negative thymic T cell selection (GO:0045060) | 4.67658859 |
9 | positive thymic T cell selection (GO:0045059) | 4.49448508 |
10 | detection of other organism (GO:0098543) | 4.40031256 |
11 | signal peptide processing (GO:0006465) | 4.39248475 |
12 | ribosomal small subunit assembly (GO:0000028) | 4.33189612 |
13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27658368 |
14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27658368 |
15 | modulation by symbiont of host immune response (GO:0052553) | 4.27658368 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27658368 |
17 | modulation by symbiont of host defense response (GO:0052031) | 4.27658368 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27658368 |
19 | positive T cell selection (GO:0043368) | 4.25196831 |
20 | detection of bacterium (GO:0016045) | 4.21678392 |
21 | B cell receptor signaling pathway (GO:0050853) | 4.06295354 |
22 | T cell selection (GO:0045058) | 3.98836108 |
23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98572014 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95909363 |
25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.93492188 |
26 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85341187 |
27 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.83660542 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77464293 |
29 | cotranslational protein targeting to membrane (GO:0006613) | 3.73408616 |
30 | protein targeting to ER (GO:0045047) | 3.72800918 |
31 | thymic T cell selection (GO:0045061) | 3.72261945 |
32 | macrophage activation involved in immune response (GO:0002281) | 3.70640781 |
33 | response to interleukin-15 (GO:0070672) | 3.64614539 |
34 | protein maturation by protein folding (GO:0022417) | 3.62776301 |
35 | regulation of tolerance induction (GO:0002643) | 3.55220162 |
36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.54933211 |
37 | protein localization to endoplasmic reticulum (GO:0070972) | 3.50366591 |
38 | detection of external biotic stimulus (GO:0098581) | 3.49730438 |
39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48924642 |
40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44320585 |
41 | cellular response to interleukin-15 (GO:0071350) | 3.42911334 |
42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.40933200 |
43 | activated T cell proliferation (GO:0050798) | 3.40625180 |
44 | viral transcription (GO:0019083) | 3.38145526 |
45 | myeloid cell activation involved in immune response (GO:0002275) | 3.38128134 |
46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37590719 |
47 | negative regulation of phagocytosis (GO:0050765) | 3.37192867 |
48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36033533 |
49 | negative regulation of interleukin-12 production (GO:0032695) | 3.35046630 |
50 | positive regulation of tolerance induction (GO:0002645) | 3.34121506 |
51 | DNA deamination (GO:0045006) | 3.32333056 |
52 | response to host immune response (GO:0052572) | 3.31100660 |
53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31100660 |
54 | translational termination (GO:0006415) | 3.30397524 |
55 | respiratory burst (GO:0045730) | 3.29473446 |
56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29408978 |
57 | regulation of T cell tolerance induction (GO:0002664) | 3.28075927 |
58 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.25569210 |
59 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.23280542 |
60 | microglial cell activation (GO:0001774) | 3.20456993 |
61 | neutrophil activation involved in immune response (GO:0002283) | 3.20048118 |
62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15606130 |
63 | detection of biotic stimulus (GO:0009595) | 3.12073509 |
64 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11621429 |
65 | sequestering of metal ion (GO:0051238) | 3.11617799 |
66 | DNA strand elongation (GO:0022616) | 3.10085114 |
67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08932708 |
68 | response to host (GO:0075136) | 3.08353087 |
69 | response to host defenses (GO:0052200) | 3.08353087 |
70 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08353087 |
71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06753814 |
72 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.06281563 |
73 | regulation of regulatory T cell differentiation (GO:0045589) | 3.02721268 |
74 | translational elongation (GO:0006414) | 3.02484359 |
75 | DNA unwinding involved in DNA replication (GO:0006268) | 3.01612526 |
76 | detection of molecule of bacterial origin (GO:0032490) | 2.97709470 |
77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97393871 |
78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95200933 |
79 | regulation of protein heterodimerization activity (GO:0043497) | 2.94447866 |
80 | telomere maintenance via recombination (GO:0000722) | 2.94306283 |
81 | neutrophil mediated immunity (GO:0002446) | 2.92016417 |
82 | T cell receptor signaling pathway (GO:0050852) | 2.91978273 |
83 | regulation of granulocyte differentiation (GO:0030852) | 2.91294579 |
84 | interferon-gamma production (GO:0032609) | 2.91003262 |
85 | regulation of mast cell degranulation (GO:0043304) | 2.87745514 |
86 | IMP biosynthetic process (GO:0006188) | 2.87057356 |
87 | macrophage activation (GO:0042116) | 2.84927288 |
88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84895508 |
89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84486253 |
90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83742434 |
91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83451716 |
92 | positive regulation of interferon-alpha production (GO:0032727) | 2.81643010 |
93 | IMP metabolic process (GO:0046040) | 2.79889968 |
94 | negative regulation of adaptive immune response (GO:0002820) | 2.79646454 |
95 | dendritic cell migration (GO:0036336) | 2.79613425 |
96 | immunoglobulin mediated immune response (GO:0016064) | 2.79390364 |
97 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.79311983 |
98 | dendritic cell chemotaxis (GO:0002407) | 2.78585200 |
99 | response to peptidoglycan (GO:0032494) | 2.77711276 |
100 | positive regulation of mast cell activation (GO:0033005) | 2.76480650 |
101 | T cell costimulation (GO:0031295) | 2.75401358 |
102 | viral life cycle (GO:0019058) | 2.74207974 |
103 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.73065035 |
104 | hepatocyte apoptotic process (GO:0097284) | 2.72354486 |
105 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71984326 |
106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71984326 |
107 | lymphocyte costimulation (GO:0031294) | 2.71386993 |
108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70459529 |
109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69886535 |
110 | DNA replication initiation (GO:0006270) | 2.68274495 |
111 | mast cell activation (GO:0045576) | 2.66139187 |
112 | mitotic recombination (GO:0006312) | 2.64266371 |
113 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.64051658 |
114 | dosage compensation (GO:0007549) | 2.63273391 |
115 | ribosomal small subunit biogenesis (GO:0042274) | 2.62779805 |
116 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61161995 |
117 | maturation of SSU-rRNA (GO:0030490) | 2.59386683 |
118 | translational initiation (GO:0006413) | 2.58802371 |
119 | leukocyte aggregation (GO:0070486) | 2.58457442 |
120 | B cell mediated immunity (GO:0019724) | 2.57351896 |
121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56831411 |
122 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.56772163 |
123 | formation of translation preinitiation complex (GO:0001731) | 2.56380740 |
124 | actin nucleation (GO:0045010) | 2.52721739 |
125 | cellular protein complex disassembly (GO:0043624) | 2.51185827 |
126 | nucleobase biosynthetic process (GO:0046112) | 2.49329725 |
127 | angiogenesis involved in wound healing (GO:0060055) | 2.48884897 |
128 | protein targeting to membrane (GO:0006612) | 2.45384324 |
129 | regulation of B cell differentiation (GO:0045577) | 2.45123049 |
130 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45031265 |
131 | positive regulation of B cell differentiation (GO:0045579) | 2.44009930 |
132 | leukocyte degranulation (GO:0043299) | 2.43900244 |
133 | cellular response to zinc ion (GO:0071294) | 2.43681752 |
134 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.43198028 |
135 | intra-S DNA damage checkpoint (GO:0031573) | 2.41937421 |
136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.39745586 |
137 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39108616 |
138 | protein retention in ER lumen (GO:0006621) | 2.38889984 |
139 | neutrophil activation (GO:0042119) | 2.38264225 |
140 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38026951 |
141 | tolerance induction (GO:0002507) | 2.36593008 |
142 | response to protozoan (GO:0001562) | 2.36002406 |
143 | telomere maintenance via telomere lengthening (GO:0010833) | 2.35178191 |
144 | defense response to protozoan (GO:0042832) | 2.34499067 |
145 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.33520279 |
146 | DNA replication checkpoint (GO:0000076) | 2.33420285 |
147 | response to fungus (GO:0009620) | 2.33074526 |
148 | negative regulation of growth of symbiont in host (GO:0044130) | 2.32699592 |
149 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.32699592 |
150 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.32699592 |
151 | regulation of growth of symbiont in host (GO:0044126) | 2.32699592 |
152 | negative regulation of cell killing (GO:0031342) | 2.32320005 |
153 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.32320005 |
154 | response to interferon-beta (GO:0035456) | 2.31838000 |
155 | myeloid leukocyte mediated immunity (GO:0002444) | 2.31808988 |
156 | T cell apoptotic process (GO:0070231) | 2.28056833 |
157 | protein complex disassembly (GO:0043241) | 2.25801575 |
158 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.25638324 |
159 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.24818326 |
160 | granulocyte activation (GO:0036230) | 2.24068042 |
161 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.22453886 |
162 | cellular response to interferon-beta (GO:0035458) | 2.22409527 |
163 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.22381574 |
164 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.20850759 |
165 | cellular extravasation (GO:0045123) | 2.20366666 |
166 | response to muramyl dipeptide (GO:0032495) | 2.20204065 |
167 | T cell migration (GO:0072678) | 2.20148248 |
168 | ribosomal large subunit biogenesis (GO:0042273) | 2.18943315 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.54603157 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46445523 |
3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.18807194 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.11673045 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84279723 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78106759 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61857589 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57853630 |
9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.55514832 |
10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49100144 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46078103 |
12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37440473 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32482435 |
14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.29607421 |
15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29441211 |
16 | MYC_22102868_ChIP-Seq_BL_Human | 2.28679975 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21360982 |
18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.16554943 |
19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.16008175 |
20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14838329 |
21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08482885 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07041753 |
23 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.05857441 |
24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05687670 |
25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04865718 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03296712 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02886007 |
28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.02461628 |
29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00727085 |
30 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00275501 |
31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94461510 |
32 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93714544 |
33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91688434 |
34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.90461263 |
35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.88418480 |
36 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88209753 |
37 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.85628796 |
38 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.85069512 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84984489 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.84942167 |
41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84710023 |
42 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.83858442 |
43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83388653 |
44 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83253855 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79977599 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78700268 |
47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75080965 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.72025177 |
49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70877524 |
50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70702145 |
51 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70680233 |
52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.67768876 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67435721 |
54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65740052 |
55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.64915255 |
56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63549738 |
57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62138195 |
58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.61377484 |
59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60946955 |
60 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60619676 |
61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.60549805 |
62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59421626 |
63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.57386674 |
64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57211173 |
65 | MYB_26560356_Chip-Seq_TH1_Human | 1.55884068 |
66 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54830328 |
67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53469473 |
68 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.51981383 |
69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51298118 |
70 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51005837 |
71 | MAF_26560356_Chip-Seq_TH1_Human | 1.50954089 |
72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49466285 |
73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48341250 |
74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47103681 |
75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46284901 |
76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46036286 |
77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45870175 |
78 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44828686 |
79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41365775 |
80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40265691 |
81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.39917150 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38900778 |
83 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38676099 |
84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37897390 |
85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37611613 |
86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36143851 |
87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33539554 |
88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33525043 |
89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31161853 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28843339 |
91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26755259 |
92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25009465 |
93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24579571 |
94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22593752 |
95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22462865 |
96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21227995 |
97 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18879925 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17818764 |
99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15769772 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13751595 |
101 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13540470 |
102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12530481 |
103 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12047595 |
104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09752172 |
105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09251717 |
106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08888515 |
107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08561633 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08052447 |
109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07266281 |
110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06798499 |
111 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06719047 |
112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06081002 |
113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05851338 |
114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05650702 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05366337 |
116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04378562 |
117 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03237993 |
118 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02068513 |
119 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01545284 |
120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01329985 |
121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01089207 |
122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97225623 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96227760 |
124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95868884 |
125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94996210 |
126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93437949 |
127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92441533 |
128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92164663 |
129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92020976 |
130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91518397 |
131 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91143382 |
132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87593122 |
133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87162902 |
134 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85545603 |
135 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85155912 |
136 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83958222 |
137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80462385 |
138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79725167 |
139 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79010636 |
140 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75958540 |
141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74235056 |
142 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71200240 |
143 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67591359 |
144 | GATA3_26560356_Chip-Seq_TH1_Human | 0.67409562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.24899177 |
2 | MP0003436_decreased_susceptibility_to | 2.98663070 |
3 | MP0003693_abnormal_embryo_hatching | 2.80204908 |
4 | MP0009785_altered_susceptibility_to | 2.77505899 |
5 | MP0002877_abnormal_melanocyte_morpholog | 2.72423976 |
6 | MP0002396_abnormal_hematopoietic_system | 2.69098203 |
7 | MP0005671_abnormal_response_to | 2.51058005 |
8 | MP0005000_abnormal_immune_tolerance | 2.45102227 |
9 | MP0003763_abnormal_thymus_physiology | 2.35518571 |
10 | MP0002009_preneoplasia | 2.28901787 |
11 | MP0003183_abnormal_peptide_metabolism | 2.28634712 |
12 | MP0002419_abnormal_innate_immunity | 2.23641965 |
13 | MP0005025_abnormal_response_to | 2.22640096 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.19632469 |
15 | MP0003303_peritoneal_inflammation | 2.19534811 |
16 | MP0000685_abnormal_immune_system | 2.14233828 |
17 | MP0003300_gastrointestinal_ulcer | 2.09388112 |
18 | MP0002420_abnormal_adaptive_immunity | 2.08270975 |
19 | MP0009333_abnormal_splenocyte_physiolog | 2.06563706 |
20 | MP0001819_abnormal_immune_cell | 2.06317089 |
21 | MP0002723_abnormal_immune_serum | 2.06077376 |
22 | MP0002452_abnormal_antigen_presenting | 2.02480297 |
23 | MP0001800_abnormal_humoral_immune | 2.01090213 |
24 | MP0003724_increased_susceptibility_to | 2.00671750 |
25 | MP0002405_respiratory_system_inflammati | 1.92075550 |
26 | MP0010094_abnormal_chromosome_stability | 1.92023046 |
27 | MP0002166_altered_tumor_susceptibility | 1.90313646 |
28 | MP0002398_abnormal_bone_marrow | 1.88889371 |
29 | MP0004808_abnormal_hematopoietic_stem | 1.85302497 |
30 | MP0008007_abnormal_cellular_replicative | 1.84425227 |
31 | MP0001790_abnormal_immune_system | 1.82743945 |
32 | MP0005387_immune_system_phenotype | 1.82743945 |
33 | MP0004957_abnormal_blastocyst_morpholog | 1.80920802 |
34 | MP0003172_abnormal_lysosome_physiology | 1.76882311 |
35 | MP0010352_gastrointestinal_tract_polyps | 1.75977211 |
36 | MP0000716_abnormal_immune_system | 1.74455218 |
37 | MP0010307_abnormal_tumor_latency | 1.73099648 |
38 | MP0010155_abnormal_intestine_physiology | 1.72475566 |
39 | MP0000490_abnormal_crypts_of | 1.71659933 |
40 | MP0000858_altered_metastatic_potential | 1.71156902 |
41 | MP0005464_abnormal_platelet_physiology | 1.71089579 |
42 | MP0002693_abnormal_pancreas_physiology | 1.70270922 |
43 | MP0003866_abnormal_defecation | 1.67408366 |
44 | MP0004381_abnormal_hair_follicle | 1.66671452 |
45 | MP0002006_tumorigenesis | 1.65071206 |
46 | MP0003077_abnormal_cell_cycle | 1.60963514 |
47 | MP0002722_abnormal_immune_system | 1.58930028 |
48 | MP0001853_heart_inflammation | 1.58852842 |
49 | MP0001845_abnormal_inflammatory_respons | 1.57518904 |
50 | MP0000703_abnormal_thymus_morphology | 1.53232878 |
51 | MP0003191_abnormal_cellular_cholesterol | 1.52481934 |
52 | MP0002429_abnormal_blood_cell | 1.52285365 |
53 | MP0005058_abnormal_lysosome_morphology | 1.51538932 |
54 | MP0000689_abnormal_spleen_morphology | 1.51049619 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.48674324 |
56 | MP0001545_abnormal_hematopoietic_system | 1.48674324 |
57 | MP0003828_pulmonary_edema | 1.48627797 |
58 | MP0005174_abnormal_tail_pigmentation | 1.48168390 |
59 | MP0004947_skin_inflammation | 1.47292856 |
60 | MP0001533_abnormal_skeleton_physiology | 1.42412099 |
61 | MP0008057_abnormal_DNA_replication | 1.39546091 |
62 | MP0008260_abnormal_autophagy | 1.38348410 |
63 | MP0008058_abnormal_DNA_repair | 1.37938090 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.37605745 |
65 | MP0005451_abnormal_body_composition | 1.30045510 |
66 | MP0004264_abnormal_extraembryonic_tissu | 1.28200522 |
67 | MP0000569_abnormal_digit_pigmentation | 1.24983386 |
68 | MP0001986_abnormal_taste_sensitivity | 1.24165811 |
69 | MP0003111_abnormal_nucleus_morphology | 1.23978699 |
70 | MP0000678_abnormal_parathyroid_gland | 1.23928202 |
71 | MP0006054_spinal_hemorrhage | 1.23519887 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.21332830 |
73 | MP0002019_abnormal_tumor_incidence | 1.20531785 |
74 | MP0002933_joint_inflammation | 1.19485992 |
75 | MP0003448_altered_tumor_morphology | 1.16327259 |
76 | MP0004782_abnormal_surfactant_physiolog | 1.15813070 |
77 | MP0002132_abnormal_respiratory_system | 1.15291194 |
78 | MP0001873_stomach_inflammation | 1.13889120 |
79 | MP0001944_abnormal_pancreas_morphology | 1.13785644 |
80 | MP0000343_altered_response_to | 1.12900201 |
81 | MP0009278_abnormal_bone_marrow | 1.11974119 |
82 | MP0009764_decreased_sensitivity_to | 1.09453182 |
83 | MP0008469_abnormal_protein_level | 1.09424118 |
84 | MP0005310_abnormal_salivary_gland | 1.08749738 |
85 | MP0005076_abnormal_cell_differentiation | 1.00503859 |
86 | MP0000350_abnormal_cell_proliferation | 0.99850781 |
87 | MP0004883_abnormal_blood_vessel | 0.98695730 |
88 | MP0005075_abnormal_melanosome_morpholog | 0.98318853 |
89 | MP0005166_decreased_susceptibility_to | 0.93721649 |
90 | MP0006082_CNS_inflammation | 0.92364634 |
91 | MP0000313_abnormal_cell_death | 0.91166489 |
92 | MP0003186_abnormal_redox_activity | 0.89131813 |
93 | MP0005220_abnormal_exocrine_pancreas | 0.88163395 |
94 | MP0009763_increased_sensitivity_to | 0.87189311 |
95 | MP0003795_abnormal_bone_structure | 0.85564253 |
96 | MP0003075_altered_response_to | 0.85555579 |
97 | MP0001851_eye_inflammation | 0.85148041 |
98 | MP0000371_diluted_coat_color | 0.84542989 |
99 | MP0005360_urolithiasis | 0.81612267 |
100 | MP0002095_abnormal_skin_pigmentation | 0.81337161 |
101 | MP0008932_abnormal_embryonic_tissue | 0.78401812 |
102 | MP0002928_abnormal_bile_duct | 0.75163623 |
103 | MP0005164_abnormal_response_to | 0.73503308 |
104 | MP0003045_fibrosis | 0.73471839 |
105 | MP0003123_paternal_imprinting | 0.73281825 |
106 | MP0003786_premature_aging | 0.72289705 |
107 | MP0000372_irregular_coat_pigmentation | 0.72096608 |
108 | MP0005390_skeleton_phenotype | 0.72050907 |
109 | MP0004185_abnormal_adipocyte_glucose | 0.72047967 |
110 | MP0000681_abnormal_thyroid_gland | 0.71771011 |
111 | MP0001730_embryonic_growth_arrest | 0.70635308 |
112 | MP0000015_abnormal_ear_pigmentation | 0.70020724 |
113 | MP0005023_abnormal_wound_healing | 0.69293068 |
114 | MP0003566_abnormal_cell_adhesion | 0.69138720 |
115 | MP0001663_abnormal_digestive_system | 0.68631942 |
116 | MP0008004_abnormal_stomach_pH | 0.68322988 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.67419822 |
118 | MP0002998_abnormal_bone_remodeling | 0.66398805 |
119 | MP0010386_abnormal_urinary_bladder | 0.65649522 |
120 | MP0002277_abnormal_respiratory_mucosa | 0.64017484 |
121 | MP0000249_abnormal_blood_vessel | 0.63684273 |
122 | MP0003890_abnormal_embryonic-extraembry | 0.61385070 |
123 | MP0001765_abnormal_ion_homeostasis | 0.58700962 |
124 | MP0002796_impaired_skin_barrier | 0.56453753 |
125 | MP0000604_amyloidosis | 0.56440895 |
126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55760620 |
127 | MP0005409_darkened_coat_color | 0.55513666 |
128 | MP0010234_abnormal_vibrissa_follicle | 0.55300465 |
129 | MP0003806_abnormal_nucleotide_metabolis | 0.54733192 |
130 | MP0003453_abnormal_keratinocyte_physiol | 0.53678380 |
131 | MP0003252_abnormal_bile_duct | 0.53587981 |
132 | MP0003091_abnormal_cell_migration | 0.52503531 |
133 | MP0002138_abnormal_hepatobiliary_system | 0.51280322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myositis (HP:0100614) | 5.01575145 |
2 | Eczematoid dermatitis (HP:0000976) | 4.58993477 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58304624 |
4 | Recurrent abscess formation (HP:0002722) | 4.23486717 |
5 | Thrombocytosis (HP:0001894) | 4.19602011 |
6 | IgM deficiency (HP:0002850) | 4.07261848 |
7 | Orchitis (HP:0100796) | 3.69329681 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.67793066 |
9 | Encephalitis (HP:0002383) | 3.47155858 |
10 | Optic neuritis (HP:0100653) | 3.46459409 |
11 | Retrobulbar optic neuritis (HP:0100654) | 3.46459409 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.44742915 |
13 | Panhypogammaglobulinemia (HP:0003139) | 3.42353363 |
14 | Papilledema (HP:0001085) | 3.40503670 |
15 | Pustule (HP:0200039) | 3.34663536 |
16 | Abnormality of T cell physiology (HP:0011840) | 3.28538642 |
17 | Autoimmune hemolytic anemia (HP:0001890) | 3.26240296 |
18 | Abnormality of T cells (HP:0002843) | 3.13831431 |
19 | Interstitial pulmonary disease (HP:0006530) | 3.07447674 |
20 | Inflammation of the large intestine (HP:0002037) | 3.06937230 |
21 | Aplastic anemia (HP:0001915) | 3.05213886 |
22 | Chronic otitis media (HP:0000389) | 3.04941481 |
23 | Increased IgE level (HP:0003212) | 2.98345609 |
24 | Agammaglobulinemia (HP:0004432) | 2.98121873 |
25 | Urticaria (HP:0001025) | 2.96696187 |
26 | Gastrointestinal inflammation (HP:0004386) | 2.95531836 |
27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95506603 |
28 | Obstructive lung disease (HP:0006536) | 2.95506603 |
29 | Vacuolated lymphocytes (HP:0001922) | 2.94328947 |
30 | T lymphocytopenia (HP:0005403) | 2.94112588 |
31 | Severe combined immunodeficiency (HP:0004430) | 2.88414949 |
32 | Prolonged bleeding time (HP:0003010) | 2.84361360 |
33 | Recurrent bronchitis (HP:0002837) | 2.81270622 |
34 | Type I transferrin isoform profile (HP:0003642) | 2.79280477 |
35 | Chronic diarrhea (HP:0002028) | 2.76960848 |
36 | Colitis (HP:0002583) | 2.76820587 |
37 | Cellulitis (HP:0100658) | 2.75450612 |
38 | Abnormality of T cell number (HP:0011839) | 2.74469980 |
39 | Mediastinal lymphadenopathy (HP:0100721) | 2.74187147 |
40 | Recurrent fungal infections (HP:0002841) | 2.74116602 |
41 | Abnormality of macrophages (HP:0004311) | 2.73558923 |
42 | Epistaxis (HP:0000421) | 2.69340848 |
43 | Meningitis (HP:0001287) | 2.64304014 |
44 | Reticulocytopenia (HP:0001896) | 2.60544325 |
45 | Dysostosis multiplex (HP:0000943) | 2.59494875 |
46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58286740 |
47 | Mucopolysacchariduria (HP:0008155) | 2.58286740 |
48 | Abnormality of the prostate (HP:0008775) | 2.55808699 |
49 | Abnormal protein glycosylation (HP:0012346) | 2.52625653 |
50 | Abnormal glycosylation (HP:0012345) | 2.52625653 |
51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52625653 |
52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52625653 |
53 | 11 pairs of ribs (HP:0000878) | 2.51100263 |
54 | Gingival bleeding (HP:0000225) | 2.50720343 |
55 | Abnormality of eosinophils (HP:0001879) | 2.48677852 |
56 | Pulmonary infiltrates (HP:0002113) | 2.46266058 |
57 | Thoracolumbar scoliosis (HP:0002944) | 2.46208772 |
58 | Hemoptysis (HP:0002105) | 2.44325992 |
59 | Agnosia (HP:0010524) | 2.44038779 |
60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43388158 |
61 | Recurrent viral infections (HP:0004429) | 2.42918577 |
62 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42447279 |
63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42267820 |
64 | Keratoconjunctivitis sicca (HP:0001097) | 2.41414088 |
65 | Pulmonary embolism (HP:0002204) | 2.40474051 |
66 | Abnormality of the anterior horn cell (HP:0006802) | 2.40345555 |
67 | Degeneration of anterior horn cells (HP:0002398) | 2.40345555 |
68 | Amyloidosis (HP:0011034) | 2.39956818 |
69 | B lymphocytopenia (HP:0010976) | 2.39658001 |
70 | Abnormality of B cell number (HP:0010975) | 2.39658001 |
71 | Spontaneous hematomas (HP:0007420) | 2.39172939 |
72 | Increased IgM level (HP:0003496) | 2.38172351 |
73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37575270 |
74 | Combined immunodeficiency (HP:0005387) | 2.36588058 |
75 | Vasculitis (HP:0002633) | 2.36090418 |
76 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.35972156 |
77 | Gangrene (HP:0100758) | 2.35562506 |
78 | Autoimmune thrombocytopenia (HP:0001973) | 2.34202551 |
79 | Papilloma (HP:0012740) | 2.31381073 |
80 | Verrucae (HP:0200043) | 2.31381073 |
81 | Hypochromic microcytic anemia (HP:0004840) | 2.29894020 |
82 | Acute myeloid leukemia (HP:0004808) | 2.29632551 |
83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28834373 |
84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28834373 |
85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28834373 |
86 | Petechiae (HP:0000967) | 2.26695602 |
87 | Skin ulcer (HP:0200042) | 2.26422793 |
88 | Recurrent skin infections (HP:0001581) | 2.24654434 |
89 | Abnormal number of erythroid precursors (HP:0012131) | 2.24535519 |
90 | Bronchitis (HP:0012387) | 2.23708025 |
91 | Viral hepatitis (HP:0006562) | 2.21553041 |
92 | Hypochromic anemia (HP:0001931) | 2.21406305 |
93 | Skin rash (HP:0000988) | 2.20488712 |
94 | Lymphoma (HP:0002665) | 2.19491710 |
95 | Anorexia (HP:0002039) | 2.19045731 |
96 | Sepsis (HP:0100806) | 2.18400625 |
97 | Reduced antithrombin III activity (HP:0001976) | 2.17143934 |
98 | Keratoconjunctivitis (HP:0001096) | 2.15151442 |
99 | Poor head control (HP:0002421) | 2.13594169 |
100 | Lymphopenia (HP:0001888) | 2.13404263 |
101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13209707 |
102 | Arterial thrombosis (HP:0004420) | 2.12408660 |
103 | Abnormality of the pleura (HP:0002103) | 2.11661391 |
104 | Chest pain (HP:0100749) | 2.10856095 |
105 | Pulmonary fibrosis (HP:0002206) | 2.08903095 |
106 | Hypoplasia of the thymus (HP:0000778) | 2.08446711 |
107 | Hypoglycemic seizures (HP:0002173) | 2.07710153 |
108 | Symptomatic seizures (HP:0011145) | 2.07306550 |
109 | IgG deficiency (HP:0004315) | 2.03859023 |
110 | Increased cerebral lipofuscin (HP:0011813) | 2.02512665 |
111 | Increased density of long bones (HP:0006392) | 2.00413892 |
112 | Osteomyelitis (HP:0002754) | 2.00347386 |
113 | Microcytic anemia (HP:0001935) | 1.99445517 |
114 | Acute hepatic failure (HP:0006554) | 1.99305513 |
115 | Glomerulopathy (HP:0100820) | 1.98760199 |
116 | IgA deficiency (HP:0002720) | 1.98042233 |
117 | Stomatitis (HP:0010280) | 1.97989880 |
118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97025532 |
119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97025532 |
120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97025532 |
121 | Amaurosis fugax (HP:0100576) | 1.97007743 |
122 | Gingivitis (HP:0000230) | 1.96861928 |
123 | Fatigue (HP:0012378) | 1.96662217 |
124 | Nasal polyposis (HP:0100582) | 1.96497887 |
125 | Colon cancer (HP:0003003) | 1.96360936 |
126 | Basal ganglia calcification (HP:0002135) | 1.95306394 |
127 | Slow saccadic eye movements (HP:0000514) | 1.94894420 |
128 | Broad face (HP:0000283) | 1.92850855 |
129 | Generalized aminoaciduria (HP:0002909) | 1.92534635 |
130 | Abnormality of the fingertips (HP:0001211) | 1.90714449 |
131 | Thyroiditis (HP:0100646) | 1.90517720 |
132 | Hypergammaglobulinemia (HP:0010702) | 1.90062529 |
133 | Progressive neurologic deterioration (HP:0002344) | 1.89723711 |
134 | Leukocytosis (HP:0001974) | 1.89602708 |
135 | Acute lymphatic leukemia (HP:0006721) | 1.89493611 |
136 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89352773 |
137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89352773 |
138 | Joint swelling (HP:0001386) | 1.89045437 |
139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88476353 |
140 | Granulocytopenia (HP:0001913) | 1.88067226 |
141 | Premature loss of primary teeth (HP:0006323) | 1.86767177 |
142 | Periodontitis (HP:0000704) | 1.86596895 |
143 | Eosinophilia (HP:0001880) | 1.86325704 |
144 | Myelodysplasia (HP:0002863) | 1.85044692 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FLT3 | 3.62252457 |
2 | PASK | 3.27501064 |
3 | TXK | 2.91121610 |
4 | TAOK3 | 2.75952297 |
5 | MAP4K1 | 2.58884496 |
6 | PRPF4B | 2.54937965 |
7 | IRAK4 | 2.54401577 |
8 | SCYL2 | 2.32082997 |
9 | CSK | 2.23612341 |
10 | IRAK3 | 2.21079996 |
11 | EIF2AK3 | 2.18490851 |
12 | KIT | 2.13594567 |
13 | ZAP70 | 1.98583993 |
14 | MAP2K3 | 1.88069738 |
15 | BLK | 1.86588065 |
16 | PIM2 | 1.80430947 |
17 | NME2 | 1.69486980 |
18 | MAP3K13 | 1.68698552 |
19 | STK16 | 1.66069015 |
20 | JAK3 | 1.65181773 |
21 | WEE1 | 1.64075958 |
22 | CDC7 | 1.62301868 |
23 | ERN1 | 1.56808214 |
24 | TNK2 | 1.55688795 |
25 | BRSK2 | 1.54218130 |
26 | RPS6KA4 | 1.52522940 |
27 | * BTK | 1.52216882 |
28 | * TEC | 1.51840749 |
29 | STK10 | 1.50050846 |
30 | TBK1 | 1.48021722 |
31 | BMPR2 | 1.46754673 |
32 | EEF2K | 1.45200319 |
33 | BUB1 | 1.45052114 |
34 | HIPK2 | 1.43250122 |
35 | LRRK2 | 1.35505158 |
36 | EIF2AK1 | 1.31776660 |
37 | TSSK6 | 1.29705230 |
38 | VRK1 | 1.28275902 |
39 | TYK2 | 1.26391854 |
40 | PIM1 | 1.23432687 |
41 | ACVR1B | 1.22156618 |
42 | MAP3K14 | 1.22097735 |
43 | TGFBR1 | 1.21509111 |
44 | PKN2 | 1.20691808 |
45 | TESK1 | 1.20346625 |
46 | SIK3 | 1.17307575 |
47 | TESK2 | 1.14296000 |
48 | NLK | 1.12580351 |
49 | CSF1R | 1.08716105 |
50 | RPS6KB2 | 1.07290892 |
51 | IKBKE | 1.00883528 |
52 | NEK2 | 1.00085516 |
53 | MAPKAPK3 | 0.99735889 |
54 | MAP3K2 | 0.99658923 |
55 | FGR | 0.98354671 |
56 | MAPK15 | 0.97418376 |
57 | LCK | 0.96010891 |
58 | CDK19 | 0.95773165 |
59 | MAP3K3 | 0.94910977 |
60 | MAP3K6 | 0.94863641 |
61 | JAK1 | 0.94563646 |
62 | MARK3 | 0.93143629 |
63 | IKBKB | 0.91799844 |
64 | PAK4 | 0.91332151 |
65 | PRKCQ | 0.90602212 |
66 | NEK9 | 0.88771868 |
67 | GRK6 | 0.87157451 |
68 | FES | 0.86509478 |
69 | * SYK | 0.86101838 |
70 | ATR | 0.85673028 |
71 | PDK1 | 0.84622803 |
72 | MAP3K11 | 0.83203371 |
73 | * ITK | 0.81303974 |
74 | MAP3K12 | 0.81124298 |
75 | MST4 | 0.78051210 |
76 | EPHB1 | 0.77743806 |
77 | TAOK1 | 0.76446803 |
78 | CAMKK2 | 0.72991332 |
79 | KSR2 | 0.72461491 |
80 | INSRR | 0.70453205 |
81 | TRIB3 | 0.69996532 |
82 | MAP3K8 | 0.69846640 |
83 | JAK2 | 0.69624267 |
84 | HCK | 0.69329807 |
85 | CLK1 | 0.68979834 |
86 | CDK7 | 0.68671634 |
87 | MAPK7 | 0.68597013 |
88 | FRK | 0.68475069 |
89 | SRPK1 | 0.68091314 |
90 | SMG1 | 0.65008187 |
91 | MAPK12 | 0.63936782 |
92 | PIK3CG | 0.63753080 |
93 | * LYN | 0.63542845 |
94 | RIPK4 | 0.63193018 |
95 | CDK12 | 0.63165718 |
96 | DYRK3 | 0.62326953 |
97 | CDK6 | 0.61438992 |
98 | FYN | 0.60677588 |
99 | MAP3K10 | 0.59706065 |
100 | PLK4 | 0.59369787 |
101 | AURKB | 0.59012868 |
102 | CAMKK1 | 0.58775054 |
103 | MAP2K2 | 0.58634424 |
104 | MAP2K6 | 0.58494807 |
105 | MATK | 0.57096799 |
106 | MAPK11 | 0.55435858 |
107 | TGFBR2 | 0.54561492 |
108 | TRPM7 | 0.54049574 |
109 | MAP3K1 | 0.52101179 |
110 | CHUK | 0.51922505 |
111 | MARK2 | 0.51440342 |
112 | FGFR3 | 0.50358375 |
113 | IRAK2 | 0.50139951 |
114 | BRSK1 | 0.49839142 |
115 | RPS6KA6 | 0.49811548 |
116 | RAF1 | 0.48607368 |
117 | PDPK1 | 0.48595800 |
118 | EPHA3 | 0.48023703 |
119 | ALK | 0.47959723 |
120 | TLK1 | 0.47863777 |
121 | STK4 | 0.47518883 |
122 | IRAK1 | 0.47395398 |
123 | CDK4 | 0.46312313 |
124 | GRK7 | 0.46071975 |
125 | BRD4 | 0.45991985 |
126 | PTK6 | 0.45669819 |
127 | CDK8 | 0.45597184 |
128 | MKNK1 | 0.45539940 |
129 | RPS6KL1 | 0.44798661 |
130 | RPS6KC1 | 0.44798661 |
131 | RET | 0.43709451 |
132 | KDR | 0.43237764 |
133 | MAP3K5 | 0.41144025 |
134 | YES1 | 0.40553641 |
135 | PLK1 | 0.40454114 |
136 | MAPKAPK2 | 0.39022777 |
137 | STK24 | 0.38467834 |
138 | MAP3K7 | 0.36511919 |
139 | SGK3 | 0.36122693 |
140 | FGFR4 | 0.35024847 |
141 | NEK6 | 0.34267771 |
142 | EGFR | 0.33882574 |
143 | DYRK1B | 0.30344141 |
144 | MELK | 0.29861895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.37137019 |
2 | Protein export_Homo sapiens_hsa03060 | 3.20197627 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 2.59129392 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.53925025 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24344114 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12967303 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.07223555 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99912884 |
9 | Legionellosis_Homo sapiens_hsa05134 | 1.95409571 |
10 | Base excision repair_Homo sapiens_hsa03410 | 1.95333314 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93445924 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77689100 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74403435 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 1.70945848 |
15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.70009285 |
16 | Spliceosome_Homo sapiens_hsa03040 | 1.68368131 |
17 | Proteasome_Homo sapiens_hsa03050 | 1.62548375 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60142705 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57863811 |
20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50307389 |
21 | Measles_Homo sapiens_hsa05162 | 1.48610879 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47808813 |
23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43414170 |
24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42380496 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41833617 |
26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39362358 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37850783 |
28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36829583 |
29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.36454939 |
30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35159092 |
31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33639365 |
32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31912988 |
33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30771580 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29710639 |
35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25326021 |
36 | Asthma_Homo sapiens_hsa05310 | 1.24835587 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24567861 |
38 | Cell cycle_Homo sapiens_hsa04110 | 1.24475704 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.24098165 |
40 | RNA transport_Homo sapiens_hsa03013 | 1.20828973 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20712721 |
42 | Allograft rejection_Homo sapiens_hsa05330 | 1.14512568 |
43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13038219 |
44 | RNA polymerase_Homo sapiens_hsa03020 | 1.12770422 |
45 | RNA degradation_Homo sapiens_hsa03018 | 1.11301745 |
46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09952336 |
47 | Pertussis_Homo sapiens_hsa05133 | 1.07878006 |
48 | Thyroid cancer_Homo sapiens_hsa05216 | 1.07745825 |
49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06853968 |
50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02174848 |
51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01612695 |
52 | Apoptosis_Homo sapiens_hsa04210 | 1.00455481 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99794374 |
54 | Shigellosis_Homo sapiens_hsa05131 | 0.99660606 |
55 | Tuberculosis_Homo sapiens_hsa05152 | 0.99186589 |
56 | Influenza A_Homo sapiens_hsa05164 | 0.98214935 |
57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97743774 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95073571 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92570548 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91935965 |
61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88700800 |
62 | Hepatitis B_Homo sapiens_hsa05161 | 0.88507517 |
63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86958962 |
64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84960247 |
65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84359688 |
66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82722833 |
67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82417639 |
68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82074100 |
69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81787614 |
70 | Phagosome_Homo sapiens_hsa04145 | 0.81193397 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80577550 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79742394 |
73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76597270 |
74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75628228 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75614021 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73967977 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73577925 |
78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72557172 |
79 | Salmonella infection_Homo sapiens_hsa05132 | 0.71839359 |
80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69348063 |
81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68999584 |
82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68607234 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68524689 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67614478 |
85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66170730 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65995494 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64697867 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64521777 |
89 | Malaria_Homo sapiens_hsa05144 | 0.62821294 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62088306 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60799778 |
92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60562569 |
93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59560181 |
94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59462857 |
95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58861050 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58084152 |
97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58008458 |
98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57919594 |
99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57324160 |
100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57170103 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57103167 |
102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56182360 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55728112 |
104 | Purine metabolism_Homo sapiens_hsa00230 | 0.54688331 |
105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52991552 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52791887 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52389280 |
108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50579800 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.50333676 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49566156 |
111 | Prostate cancer_Homo sapiens_hsa05215 | 0.49552250 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.49430900 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48552115 |
114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47166566 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44655605 |
116 | Endocytosis_Homo sapiens_hsa04144 | 0.44364834 |
117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42104715 |
118 | Platelet activation_Homo sapiens_hsa04611 | 0.41865648 |
119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41711423 |
120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40372368 |
121 | Hepatitis C_Homo sapiens_hsa05160 | 0.40066933 |
122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39567555 |
123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39014229 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38668776 |
125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38286261 |
126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37681863 |
127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36441534 |
128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35627576 |
129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34788499 |
130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33228214 |
131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33025857 |
132 | Glioma_Homo sapiens_hsa05214 | 0.30685699 |
133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30197002 |
134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29207932 |